These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 27561697)
1. Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia. Shimizu H; Kobayashi N; Mihara M; Iriuchishima H; Ishizaki T; Kojima Y; Handa H Acta Haematol; 2016; 136(3):174-7. PubMed ID: 27561697 [TBL] [Abstract][Full Text] [Related]
2. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia]. Nagata H; Fujino T; Muramatsu A; Kawaji Y; Kuriyama K; Oshiro M; Hirakawa Y; Iwai T; Uchiyama H Rinsho Ketsueki; 2018; 59(4):407-413. PubMed ID: 29743400 [TBL] [Abstract][Full Text] [Related]
3. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature. Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review. Mashima K; Yano S; Yokoyama H; Saito T; Machishima T; Shimada T; Yahagi Y; Takahara S; Sugiyama K; Ogasawara Y; Minami J; Kamiyama Y; Katsube A; Suzuki K; Ohshima S; Yamada H; Usui N; Aiba K Intern Med; 2017; 56(6):701-706. PubMed ID: 28321074 [TBL] [Abstract][Full Text] [Related]
8. Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A. Takahashi T; Maruyama Y; Saitoh M; Itoh H; Yoshimoto M; Tsujisaki M Case Rep Hematol; 2015; 2015():926874. PubMed ID: 26425376 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia. Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802 [TBL] [Abstract][Full Text] [Related]
10. Manifestations of fulminant CD8 T-cell post-transplant lymphoproliferative disorder following the administration of rituximab for lymphadenopathy with a high level of Epstein-Barr Virus (EBV) replication after allogeneic hematopoietic stem cell transplantation. Tanaka T; Takizawa J; Miyakoshi S; Kozakai T; Fuse K; Shibasaki Y; Moriyama M; Ohshima K; Toba K; Furukawa T; Sone H; Masuko M Intern Med; 2014; 53(18):2115-9. PubMed ID: 25224199 [TBL] [Abstract][Full Text] [Related]
11. An Epstein-Barr virus-associated leukemic lymphoma in a patient treated with rabbit antithymocyte globulin and cyclosporine for hepatitis-associated aplastic anemia. Ohata K; Iwaki N; Kotani T; Kondo Y; Yamazaki H; Nakao S Acta Haematol; 2012; 127(2):96-9. PubMed ID: 22178718 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients. Meijer E; Cornelissen JJ Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928 [TBL] [Abstract][Full Text] [Related]
13. [Elevation of Epstein-Barr virus (EBV)-DNA in the peripheral blood of a patient with age-related EBV-associated B-cell lymphoproliferative disorder]. Tanioka R; Mori S; Nakanishi T; Fujita S; Nakamichi N; Tajima K; Uemura Y; Amakawa R; Kishimoto Y; Fukuhara S Rinsho Ketsueki; 2007 Nov; 48(11):1492-7. PubMed ID: 18080508 [TBL] [Abstract][Full Text] [Related]
14. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia. Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187 [TBL] [Abstract][Full Text] [Related]
15. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. van Esser JW; Niesters HG; Thijsen SF; Meijer E; Osterhaus AD; Wolthers KC; Boucher CA; Gratama JW; Budel LM; van der Holt B; van Loon AM; Löwenberg B; Verdonck LF; Cornelissen JJ Br J Haematol; 2001 Jun; 113(3):814-21. PubMed ID: 11380475 [TBL] [Abstract][Full Text] [Related]